Abstract
AimBoron Neutron Capture Therapy (BNCT) is a binary hadrontherapy which exploits the neutron capture reaction in boron, together with a selective uptake of boronated substances by the neoplastic tissue. There is increasing evidence that future improvements in clinical BNCT will be triggered by the discovery of new boronated compounds, with higher selectivity for the tumor with respect to clinically used sodium borocaptate (BSH) and boronophenylalanine (BPA). BackgroundTherefore, a 10B quantification technique for biological samples is needed in order to evaluate the performance of new boronated formulations. Materials and methodsThis article describes an improved neutron autoradiography set-up employing radiation sensitive films where the latent tracks are made visible by proper etching conditions. ResultsCalibration curves for both liquid and tissue samples were obtained. ConclusionsThe obtained calibration curves were adopted to set-up a mechanism to point out boron concentration in the whole sample.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have